The Ozempic Lawsuit was officially consolidated into multidistrict litigation (MDL) in early 2024, as the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation (MDL 3094)
Extended-release formulations may behave somewhat differently, and if youre on a medication with a narrow therapeutic window, its worth raising the question directly with your prescriber or pharmacist
You dial your dose, click, and inject
Zappy Health supports patients through a combination of medical care, behavioral coaching, and access to GLP-1-based medications when appropriate
Some people benefit from ongoing treatment For those who often regain weight, have metabolic conditions or have strong appetite drivers, staying on treatment long term may offer stability
It impairs liver function, which affects glucose metabolism